Promotion of lung cancer growth via glutamate ionotropic receptor N-methyl-D-aspartate-type subunit 2D (GRIN2D)

Key Points

• Lung cancer growth is promoted by the glutamate receptor GRIN2D, altering traditional understanding of its role.
• The involvement of GRIN2D in lung cancer has been established through novel findings, prompting new research directions.
• Observational analysis sheds light on the underlying mechanisms influenced by GRIN2D in cancer biology.
• These insights may enable ketamine's use as a therapeutic beyond its current applications, pushing forward cancer treatment options.